Mallinckrodt PLC (NYSE:MNK) shares increased 0.51% in last trading session and ended the day at $71.24. MNK Gross Margin is 55.40% and its has a return on assets of 2.90%. Mallinckrodt PLC (NYSE:MNK) quarterly performance is -13.21%.
On 7 December, Mallinckrodt plc (MNK), held its investor briefing in New York City with presentations by Mark Trudeau, President and Chief Executive Officer of Mallinckrodt and Steve Romano, M.D., Chief Scientific Officer.
Equinix, Inc. (NASDAQ:EQIX) ended the last trading day at $295.65. Company weekly volatility is calculated as 2.19% and price to cash ratio as 52.78. Equinix, Inc. (NASDAQ:EQIX) showed a weekly performance of 0.71%.
Equinix, Inc. (NASDAQ:EQIX), announced that it has completed the acquisition of the remaining outstanding shares of Bit-isle, Inc. This acquisition further strengthens Equinix’s position in Asia-Pacific—the company’s fastest growing region—improving the company’s market position in Japan, and helps to meet growing demand for interconnection among Japanese businesses. With the acquisition of Bit-isle’s six facilities, Platform Equinix™ now includes 111 data centers in 33 markets around the world.
On 10 December, Citizens Community Bancorp, Inc. (NASDAQ:CZWI) shares decreased -0.85% and was closed at $9.32. CZWI EPS growth in last 5 year was 18.70%. Citizens Community Bancorp, Inc. (NASDAQ:CZWI) year to date (YTD) performance is 1.91%.
GoPro, Inc. (NASDAQ:GPRO) shares increased 11.49% in last trading session and ended the day at $18.83. GPRO Gross Margin is 46.70% and its has a return on assets of 17.00%. GoPro, Inc. (NASDAQ:GPRO) quarterly performance is -41.92%.
GoPro, Inc. (NASDAQ: GPRO) announced the launch of Apple Watch features in the GoPro App for iOS to enable quick access to the camera’s controls right from the wrist. This new app allows users to preview their shot, toggle between capture modes, start/stop record and add HiLight Tags to the best moments of their videos.
Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) caters to the Healthcare space. Its weekly performance is 2.69%. On the last day of trading company shares ended up at $4.20. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) distance from 50-day simple moving average (SMA50) is 24.85%.
Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) reported a net loss of approximately $15.2 million, or ($0.54) per share, compared to a net loss of approximately $9.1 million, or ($0.41) per share in the same period of 2014. For the fiscal year ended September 30, 2015, total operating expenses were approximately $17.8 million, consisting of $7.5 million in general and administrative expenses, $8.8 million in research and development expenses, $1.2 million in depreciation and amortization, and $0.3 million in impairment of intangibles.